In CD8+ T-cell subset, CD39+ cells did not significantly differ between healthy controls and ischemic stroke patients with frequency values of 4.09% ± 0.53% and 6.50% ± 0.90%, respectively (p = 0.0565, Figure 5a,b, Table 3). This evidence concerns the gene ENTPD1 and ischemic stroke.